METOJECT SUBCUTANEOUS
Google image searchProduct monograph
Active ingredient
methotrexate (methotrexate sodium), 20 MG/0.4 ML
DIN: 02454866
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE PREFILLED SYRINGES
Schedule: Prescription
Company: MEDEXUS PHARMACEUTICALS INC.
Date: 02-DEC-2016
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AX — Other immunosuppressants (ATC, ATC/DDD)
- L04AX03 — METHOTREXATE (ATC/DDD)
Pharmaceutical standard: MFR
